Search

Author/Creator Silverberg, J. I.

8. Baricitinib improves symptoms in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: patient-reported outcomes from two randomized monotherapy phase III trials. (3rd April 2022)

Authors:
Reich, K.; DeLozier, A. M.; Nunes, F. P.; Thyssen, J. P.; Eichenfield, L. F.; Wollenberg, A.; Ross Terres, J. A.; Watts, S. D.; Chen, Y.-F.; Simpson, E. L.; Silverberg, J. I.
Journal:
Journal of dermatological treatment
Issue:
Volume 33:Number 3(2022)
Page Start:
1521
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Dupilumab provides rapid and sustained improvement in SCORAD outcomes in adults with moderate-to-severe atopic dermatitis: combined results of four randomized phase 3 trials. (2nd January 2022)

Authors:
Barbarot, S.; Wollenberg, A.; Silverberg, J. I.; Deleuran, M.; Pellacani, G.; Armario-Hita, J. C.; Chen, Z.; Shumel, B.; Eckert, L.; Gadkari, A.; Lu, Y.; Rossi, A. B.
Journal:
Journal of dermatological treatment
Issue:
Volume 33:Number 1(2022)
Page Start:
266
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Estimands for atopic dermatitis clinical trials: Expert opinion on the importance of intercurrent events. (25th February 2023)

Authors:
Bissonnette, R.; Eichenfield, L. F.; Simpson, E.; Thaçi, D.; Kabashima, K.; Thyssen, J. P.; Guttman‐Yassky, E.; Nunes, F. P.; Gamalo, M.; Ahmad, F.; Kuligowski, M.; Sun, K.; Pipper, C.; Christensen, A. W.; D'Angelo, P.; Milutinovic, M.; Guettner, A.; Silverberg, J. I.
Journal:
Journal of the European Academy of Dermatology and Venereology
Issue:
Volume 37:Number 5(2023)
Page Start:
976
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗